Kremlin Wickramasinghe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Recognitions
Kremlin Wickramasinghe has a total of 373 co-authors. Here are the top co-authors by number of shared publications:
- Nick Townsend
University of Bristol
20 shared publications Mike Rayner
Nuffield Department of Population Health, University of Oxford, Oxford, UK
18 shared publications- Julianne Williams
University of Oxford
16 shared publications Karen McColl
13 shared publications- Shanthi Mendis
Chronic Disease Prevention and Management, World Health Organization, Geneva, Switzerland
13 shared publications - Holly Rippin
Special Initiative on NCDs and Innovation, World Health Organization Regional Office for Europe, DK-2100 Copenhagen, Denmark
11 shared publications
Latest Publications
- Open Access
- 5 October 2026
- Published by Ministerio de Sanidad del Gobierno de España in Revista Espanola de Salud Publica
- Vol. 100
Obesidad infantil en España: quince años de seguimiento y actuación a través de la Iniciativa europea de Vigilancia de la Obesidad Infantil (COSI) de la OMS y el estudio ALADINO
El exceso de peso y la obesidad infantil representan un urgente desafío de Salud Pública en Europa, con consecuencias para la salud, el bienestar y la calidad de vida de esta población, que proyectan una carga significativa en los sistemas sanitarios y económicos. Disponer de datos fiables y comparables es clave para orientar respuestas eficaces. En consecuencia, la Oficina Regional para Europa de la Organización Mundial de la Salud (OMS) lanzó en 2007 la Iniciativa de Vigilancia de Obesidad Infantil (COSI) para armonizar la recopilación de datos antropométricos de menores entre seis y nueve años. Desde su inicio, COSI ha pasado de trece a cuarenta y ocho países participantes, con datos de aproximadamente 1,6 millones de menores a lo largo de más de quince años. España participa en COSI desde 2009-2010 a través del estudio ALADINO, proporcionando datos de gran calidad y representatividad nacional. La última ronda (2022-2023) incluyó 12.684 escolares, con una prevalencia de exceso de peso de 33,6% a los seis años y 40,5% a los nueve, y de obesidad entre el 14,1% y el 18,8%, respectivamente. A pesar de lograr una de las mayores reducciones en exceso de peso entre la ronda 5ª y 6ª de COSI, España continúa entre los países con mayores prevalencias de la región.Esta publicación destaca el valor de la colaboración internacional mediante la iniciativa COSI, consolidada como un sistema de vigilancia armonizado y de gran solidez científica, imprescindible para el impulso de políticas dirigidas a prevenir la obesidad infantil en toda Europa. Sus resultados en España han apoyado intervenciones nacionales, favorecido el conocimiento de la situación ponderal y hábitos de vida de los menores en la región, y posicionado al país como uno de los pioneros del Plan de Aceleración de la OMS para Detener la Obesidad, contribuyendo así a la protección de la salud de la infancia en España y en la región europea.
- 5 October 2026
- Published by Ministerio de Sanidad del Gobierno de España in Revista Espanola de Salud Publica
- Vol. 100
Open AccessObesidad infantil en España: quince años de seguimiento y actuación a través de la Iniciativa europea de Vigilancia de la Obesidad Infantil (COSI) de la OMS y el estudio ALADINO
El exceso de peso y la obesidad infantil representan un urgente desafío de Salud Pública en Europa, con consecuencias para la salud, el bienestar y la calidad de vida de esta población, que proyectan una carga significativa en los sistemas sanitarios y económicos. Disponer de datos fiables y comparables es clave para orientar respuestas eficaces. En consecuencia, la Oficina Regional para Europa de la Organización Mundial de la Salud (OMS) lanzó en 2007 la Iniciativa de Vigilancia de Obesidad Infantil (COSI) para armonizar la recopilación de datos antropométricos de menores entre seis y nueve años. Desde su inicio, COSI ha pasado de trece a cuarenta y ocho países participantes, con datos de aproximadamente 1,6 millones de menores a lo largo de más de quince años. España participa en COSI desde 2009-2010 a través del estudio ALADINO, proporcionando datos de gran calidad y representatividad nacional. La última ronda (2022-2023) incluyó 12.684 escolares, con una prevalencia de exceso de peso de 33,6% a los seis años y 40,5% a los nueve, y de obesidad entre el 14,1% y el 18,8%, respectivamente. A pesar de lograr una de las mayores reducciones en exceso de peso entre la ronda 5ª y 6ª de COSI, España continúa entre los países con mayores prevalencias de la región.Esta publicación destaca el valor de la colaboración internacional mediante la iniciativa COSI, consolidada como un sistema de vigilancia armonizado y de gran solidez científica, imprescindible para el impulso de políticas dirigidas a prevenir la obesidad infantil en toda Europa. Sus resultados en España han apoyado intervenciones nacionales, favorecido el conocimiento de la situación ponderal y hábitos de vida de los menores en la región, y posicionado al país como uno de los pioneros del Plan de Aceleración de la OMS para Detener la Obesidad, contribuyendo así a la protección de la salud de la infancia en España y en la región europea.
- 16 December 2025
- Published by SAGE Publications in Scandinavian Journal of Public Health
- Vol. 53 (3_suppl) , 3-5
Prevention of noncommunicable diseases: Where we are and what’s next in the WHO European region?
Noncommunicable diseases (NCDs) account for the majority of mortality and morbidity in the World Health Organization (WHO) European region, largely driven by modifiable commercial determinants. Despite strong evidence supporting cost-effective interventions, implementation has been inconsistent due to industry interference, limited resources and policy inertia. To address this, WHO/Europe has identified a set of ‘quick buys’ capable of producing measurable health outcomes within 5 years. Experience shows that voluntary measures, pilot projects and the exchange of good practices alone are insufficient to achieve the 2030 Sustainable Development Goal (SDG) targets, making mandatory, well-enforced policies urgently needed to deliver the scale and speed of change required. As the 2030 SDG deadline approaches, accelerating policy action, strengthening surveillance systems and safeguarding public health governance from commercial interests are essential to reducing the NCD burden and achieving regional health targets.
- 16 December 2025
- Published by SAGE Publications in Scandinavian Journal of Public Health
- Vol. 53 (3_suppl) , 3-5
Prevention of noncommunicable diseases: Where we are and what’s next in the WHO European region?
Noncommunicable diseases (NCDs) account for the majority of mortality and morbidity in the World Health Organization (WHO) European region, largely driven by modifiable commercial determinants. Despite strong evidence supporting cost-effective interventions, implementation has been inconsistent due to industry interference, limited resources and policy inertia. To address this, WHO/Europe has identified a set of ‘quick buys’ capable of producing measurable health outcomes within 5 years. Experience shows that voluntary measures, pilot projects and the exchange of good practices alone are insufficient to achieve the 2030 Sustainable Development Goal (SDG) targets, making mandatory, well-enforced policies urgently needed to deliver the scale and speed of change required. As the 2030 SDG deadline approaches, accelerating policy action, strengthening surveillance systems and safeguarding public health governance from commercial interests are essential to reducing the NCD burden and achieving regional health targets.
- Open Access
- 14 October 2025
- Published by Federal Research Institute for Health Organization and Informatics in Public Health
- Vol. 5 (3) , 4-16
Implementation of policies to reduce risk factors for noncommunicable diseases in the European region: the contribution of the WHO NCD Office in Moscow
Introduction. Noncommunicable diseases (NCDs) are the leading cause of mortality in the WHO European Region, accounting for up to 90% of all deaths. To support Member States in the Region with NCD prevention and control, the WHO European Office for the Prevention and Control of NCDs was established in Moscow in 2012 with the support of the Russian Federation. The purpose of the study: to provide an overview of the key areas of work of the WHO NCD Office in Moscow, its contribution to strengthening the capacity of countries in the European Region, and the promotion of effective, evidence-based measures in NCD control. Materials and methods. In the course of this study, the Office’s internal accounting documents and materials published by its employees, including those within the framework of projects supported by it, were analyzed. Results. Over more than a decade of work, the Office has played a significant role in promoting public health policies and best practices, with a particular focus on reducing exposure to risk factors such as tobacco use, excessive alcohol consumption, unhealthy diets, and insufficient physical activity. The Office has contributed to strengthening surveillance and risk factor monitoring through large-scale studies and the implementation of digital data analysis tools, as well as to the development of health systems for managing chronic conditions at the primary care level. Important contributions include innovative solutions, such as monitoring digital marketing of unhealthy products, as well as the development of educational initiatives, networking platforms for young professionals, and intersectoral and international cooperation. At the country level, support was provided in developing legislation, implementing prevention programmes, establishing patient registries, and improving access to healthcare services, thereby strengthening national efforts to combat NCDs. Conclusion. In the course of its work, the WHO NCD Office has become a key regional centre for expert, methodological, and technical support to Member States in the WHO European Region on NCD prevention and control, promoting evidence-based and innovative solutions. Ongoing challenges require further strengthening of political commitment, sustainable financing, intersectoral collaboration, and the use of innovative approaches to effectively reduce the NCD burden and achieve the health-related Sustainable Development Goals in the WHO European Region.
- 14 October 2025
- Published by Federal Research Institute for Health Organization and Informatics in Public Health
- Vol. 5 (3) , 4-16
Open AccessImplementation of policies to reduce risk factors for noncommunicable diseases in the European region: the contribution of the WHO NCD Office in Moscow
Introduction. Noncommunicable diseases (NCDs) are the leading cause of mortality in the WHO European Region, accounting for up to 90% of all deaths. To support Member States in the Region with NCD prevention and control, the WHO European Office for the Prevention and Control of NCDs was established in Moscow in 2012 with the support of the Russian Federation. The purpose of the study: to provide an overview of the key areas of work of the WHO NCD Office in Moscow, its contribution to strengthening the capacity of countries in the European Region, and the promotion of effective, evidence-based measures in NCD control. Materials and methods. In the course of this study, the Office’s internal accounting documents and materials published by its employees, including those within the framework of projects supported by it, were analyzed. Results. Over more than a decade of work, the Office has played a significant role in promoting public health policies and best practices, with a particular focus on reducing exposure to risk factors such as tobacco use, excessive alcohol consumption, unhealthy diets, and insufficient physical activity. The Office has contributed to strengthening surveillance and risk factor monitoring through large-scale studies and the implementation of digital data analysis tools, as well as to the development of health systems for managing chronic conditions at the primary care level. Important contributions include innovative solutions, such as monitoring digital marketing of unhealthy products, as well as the development of educational initiatives, networking platforms for young professionals, and intersectoral and international cooperation. At the country level, support was provided in developing legislation, implementing prevention programmes, establishing patient registries, and improving access to healthcare services, thereby strengthening national efforts to combat NCDs. Conclusion. In the course of its work, the WHO NCD Office has become a key regional centre for expert, methodological, and technical support to Member States in the WHO European Region on NCD prevention and control, promoting evidence-based and innovative solutions. Ongoing challenges require further strengthening of political commitment, sustainable financing, intersectoral collaboration, and the use of innovative approaches to effectively reduce the NCD burden and achieve the health-related Sustainable Development Goals in the WHO European Region.
- Open Access
- 27 June 2025
- Published by Elsevier in Public Health in Practice
- Vol. 10, 100637
Inequalities in childhood overweight and obesity: A call to strengthen upstream policy measures
- 27 June 2025
- Published by Elsevier in Public Health in Practice
- Vol. 10, 100637
Open AccessInequalities in childhood overweight and obesity: A call to strengthen upstream policy measures
- Open Access
- 5 March 2025
- Published by Springer Nature in European Journal of Nutrition
- Vol. 64 (3) , 1-18
Diet, fruit and vegetables and One Health: benefits for health, environment, society and the consumer—proceedings of the 9th edition of EGEA conference
Purpose To present the outcomes of the EGEA Conference on the state of knowledge regarding the contribution of diets rich in fruit and vegetables (FV) to human and planetary health, commonly included in the One Health concept. Methods The 9th edition of EGEA Conference (20–22 September 2023, Barcelona) provided a transversal and multidisciplinary perspective on the contribution of FV to One Health, in particular to the health of individuals, society and the planet. Nearly 150 international scientists and stakeholders discussed the current state of knowledge. These proceedings are based both on a literature review and the scientific studies presented by the speakers. Results Scientific evidence confirms the role of FV in preventing cardiovascular diseases and type 2 diabetes; more evidence is needed on the effects and mechanisms of FV in cancer prevention. FV production and consumption helps ensure territorial cohesion and provides a denser, nutrient-rich diet with less environmental impact (except water use) than other food groups, but use of synthetic pesticides in FV production remains a challenge that could be addressed with agro-ecological solutions. Various factors influence consumer choice and behaviour towards FV consumption across the lifespan, with specific periods being more conducive to change. New research is emerging on the role of FV consumption in regulating gut microbiota and on both mental and brain health; the potential role of FV production and supply in tackling biodiversity loss and climate change; and better monitoring of FV consumption. Conclusion Sufficient evidence confirms the contribution of diet rich in FV to One Health, with some emerging research on this topic. Concerted actions are required towards an increased consumption of FV and a more diversified and environmentally neutral FV production.
- 5 March 2025
- Published by Springer Nature in European Journal of Nutrition
- Vol. 64 (3) , 1-18
Open AccessDiet, fruit and vegetables and One Health: benefits for health, environment, society and the consumer—proceedings of the 9th edition of EGEA conference
Purpose To present the outcomes of the EGEA Conference on the state of knowledge regarding the contribution of diets rich in fruit and vegetables (FV) to human and planetary health, commonly included in the One Health concept. Methods The 9th edition of EGEA Conference (20–22 September 2023, Barcelona) provided a transversal and multidisciplinary perspective on the contribution of FV to One Health, in particular to the health of individuals, society and the planet. Nearly 150 international scientists and stakeholders discussed the current state of knowledge. These proceedings are based both on a literature review and the scientific studies presented by the speakers. Results Scientific evidence confirms the role of FV in preventing cardiovascular diseases and type 2 diabetes; more evidence is needed on the effects and mechanisms of FV in cancer prevention. FV production and consumption helps ensure territorial cohesion and provides a denser, nutrient-rich diet with less environmental impact (except water use) than other food groups, but use of synthetic pesticides in FV production remains a challenge that could be addressed with agro-ecological solutions. Various factors influence consumer choice and behaviour towards FV consumption across the lifespan, with specific periods being more conducive to change. New research is emerging on the role of FV consumption in regulating gut microbiota and on both mental and brain health; the potential role of FV production and supply in tackling biodiversity loss and climate change; and better monitoring of FV consumption. Conclusion Sufficient evidence confirms the contribution of diet rich in FV to One Health, with some emerging research on this topic. Concerted actions are required towards an increased consumption of FV and a more diversified and environmentally neutral FV production.
- Open Access
- 28 October 2024
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 34 (Supplement)
Reducing obesity and overweight: Subregional Policy Dialogues in the WHO European Region
In the WHO European Region, obesity and overweight stand as leading causes of disability and premature mortality. They contribute significantly to the burden of noncommunicable diseases, hindering efforts to achieve sustainable development goals related to health, including SDG goal 3.4, aiming to reduce premature mortality from NCDs by one-third by 2030. Despite some policy successes such as sugary drinks taxes, restrictions on marketing unhealthy products to children, and physical activity promotion campaigns, no country has managed to halt the rising levels of obesity. Addressing obesity requires a comprehensive approach, and WHO endeavors to support countries in implementing a wide range of policy actions across various settings. The WHO Special Initiative for NCDs and Innovation has recently adopted a subregional approach to promote evidence-based, data-informed policy action. In June 2022, it organized a series of obesity dialogues, including sessions for the Western Balkans. This session will outline the methods and outcomes of these dialogues, including stakeholder engagement, presentation of the latest obesity data, evidence-based policy recommendations, and the process of prioritizing policy options with decision-makers. It will consider the lessons learned from this process, offering insights not only for the health agenda but also for addressing other complex public health, environmental, or social challenges, which require multisectoral collaboration and comprehensive, policy actions on many levels.
- 28 October 2024
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 34 (Supplement)
Open AccessReducing obesity and overweight: Subregional Policy Dialogues in the WHO European Region
In the WHO European Region, obesity and overweight stand as leading causes of disability and premature mortality. They contribute significantly to the burden of noncommunicable diseases, hindering efforts to achieve sustainable development goals related to health, including SDG goal 3.4, aiming to reduce premature mortality from NCDs by one-third by 2030. Despite some policy successes such as sugary drinks taxes, restrictions on marketing unhealthy products to children, and physical activity promotion campaigns, no country has managed to halt the rising levels of obesity. Addressing obesity requires a comprehensive approach, and WHO endeavors to support countries in implementing a wide range of policy actions across various settings. The WHO Special Initiative for NCDs and Innovation has recently adopted a subregional approach to promote evidence-based, data-informed policy action. In June 2022, it organized a series of obesity dialogues, including sessions for the Western Balkans. This session will outline the methods and outcomes of these dialogues, including stakeholder engagement, presentation of the latest obesity data, evidence-based policy recommendations, and the process of prioritizing policy options with decision-makers. It will consider the lessons learned from this process, offering insights not only for the health agenda but also for addressing other complex public health, environmental, or social challenges, which require multisectoral collaboration and comprehensive, policy actions on many levels.
- Open Access
- 9 September 2024
- Published by BMJ in BMJ Global Health
- Vol. 9 (9) , e016301
Nutrition remains a top priority in Ukraine despite the ongoing war: the fight against trans fats
- 9 September 2024
- Published by BMJ in BMJ Global Health
- Vol. 9 (9) , e016301
Open AccessNutrition remains a top priority in Ukraine despite the ongoing war: the fight against trans fats
- 28 June 2024
- Published by Morressier GmbH
OC149 - Comparing compliance of the UK and Kyrgyzstan baby food products with WHO Nutrient and Promotion Profile Model guidelines
Optimal nutrition during infancy and early childhood is crucial for promoting healthy growth, development, and overall well-being (1). Concerns a | POSTER
- 28 June 2024
- Published by Morressier GmbH
OC149 - Comparing compliance of the UK and Kyrgyzstan baby food products with WHO Nutrient and Promotion Profile Model guidelines
Optimal nutrition during infancy and early childhood is crucial for promoting healthy growth, development, and overall well-being (1). Concerns a | POSTER
- Open Access
- 24 June 2024
- Published by Elsevier in Clinical Nutrition
- Vol. 43 (8) , 1815-1824
Nutrition for the older adult – Current concepts. Report from an ESPEN symposium
- 24 June 2024
- Published by Elsevier in Clinical Nutrition
- Vol. 43 (8) , 1815-1824
Open AccessNutrition for the older adult – Current concepts. Report from an ESPEN symposium